Key Highlights

● BIO-key traded around $2.71 in early afternoon on October 22, not a confirmed close.

● BIO-key announced another Middle East government contract.

● The company did not disclose the dollar value of the deal.

● BIO-key is a micro-cap with a market value of roughly $4.6 million.

Shares of BIO-key International (NASDAQ:BKYI) soared on Thursday, October 22, 2026, after the biometric identity company announced another government contract in the Middle East, making it one of the standout gainers on the Nasdaq Composite.

The stock traded around $2.71 in early afternoon, according to a 1:05 PM ET market snapshot, after jumping sharply before the opening bell. Those figures are intraday readings rather than a confirmed closing price. BIO-key is a micro-cap company, with a market value of roughly $4.6 million.

The contract

BIO-key said it had won another contract with a Middle East government customer for its biometric identity and access management solutions, including its PortalGuard platform. The company did not disclose the dollar value of the deal.

PortalGuard is BIO-key's software for managing how users sign in to systems, combining passwords, multi-factor authentication and biometrics such as fingerprints. Governments use tools like these to control access to sensitive networks and services.

The word "another" matters. BIO-key put out a similar release on October 13, and the latest announcement may involve the same customer. Traders appeared to welcome the prospect of deeper ties with government buyers in the region.

Why a small deal can move a small stock

For a company valued at only a few million dollars, any new government contract can carry outsized weight. If the latest award does involve a returning customer, it would point to repeat business, which investors in small software companies tend to prize.

That said, micro-cap stocks are often thinly traded, and their prices can swing sharply in either direction on relatively modest news. Without a disclosed contract value, it is difficult to gauge how much the latest deal will contribute to BIO-key's revenue.

A good day for security software

BIO-key's rise coincided with a strong session for cybersecurity stocks more broadly. CrowdStrike (NASDAQ:CRWD), Okta (NASDAQ:OKTA), Palo Alto Networks (NASDAQ:PANW), Zscaler (NASDAQ:ZS), Check Point (NASDAQ:CHKP) Software and Cloudflare (NYSE:NET) all gained, even as the wider technology sector sold off.

That strength stood in sharp contrast to the rest of tech. AI and chip stocks were hammered after Meta Platforms (NASDAQ:META) reported heavy AI spending and negative free cash flow, and Lam Research (NASDAQ:LRCX) warned of supply constraints into 2027. The Philadelphia Semiconductor Index had its biggest one-day drop since June 23, according to market data.

The wider market

The Nasdaq Composite fell 694.00 points to 26,008.86, its steepest drop since June 5, and lost about $1 trillion in market value, according to market data. Decliners outnumbered advancers on the Nasdaq by 2,766 to 2,022.

Away from tech, buyers were active. About two of every three S&P 500 stocks rose, according to market reports. Consumer staples had their best day since April 2025, health care hit a record high, and the Russell 2000 edged up 3.01 points to 2,784.03.

BIO-key Needs to Disclose the Contract's Value

Investors will look for any disclosure of the contract's value or timing, which would help clarify its financial impact. Further government wins in the region would strengthen the case that BIO-key is building a durable foothold there. As with many micro-cap stocks, the shares may remain volatile in the days after a sharp move, particularly if no further details emerge.